These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26514023)

  • 1. Is There a Role for Statins in Palliative Care for Patients Suffering from Hepatocellular Carcinoma?
    Björkhem-Bergman L
    J Palliat Care; 2015; 31(3):172-6. PubMed ID: 26514023
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatocellular Carcinoma and Statins.
    Alipour Talesh G; Trézéguet V; Merched A
    Biochemistry; 2020 Sep; 59(37):3393-3400. PubMed ID: 32865979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pleiotropic effects of statins in the diseases of the liver.
    Janicko M; Drazilova S; Pella D; Fedacko J; Jarcuska P
    World J Gastroenterol; 2016 Jul; 22(27):6201-13. PubMed ID: 27468210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy of inoperable cancers of the exocrine pancreas and liver].
    Knuth A
    Z Gastroenterol Verh; 1991 Mar; 26():219. PubMed ID: 1714154
    [No Abstract]   [Full Text] [Related]  

  • 5. Potential for statins in the chemoprevention and management of hepatocellular carcinoma.
    Lonardo A; Loria P
    J Gastroenterol Hepatol; 2012 Nov; 27(11):1654-64. PubMed ID: 22849701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial cholesterol contributes to chemotherapy resistance in hepatocellular carcinoma.
    Montero J; Morales A; Llacuna L; Lluis JM; Terrones O; Basañez G; Antonsson B; Prieto J; García-Ruiz C; Colell A; Fernández-Checa JC
    Cancer Res; 2008 Jul; 68(13):5246-56. PubMed ID: 18593925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?
    Goh MJ; Sinn DH
    Clin Mol Hepatol; 2022 Jul; 28(3):380-395. PubMed ID: 35021597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review with network meta-analysis: statins and risk of hepatocellular carcinoma.
    Zhou YY; Zhu GQ; Wang Y; Zheng JN; Ruan LY; Cheng Z; Hu B; Fu SW; Zheng MH
    Oncotarget; 2016 Apr; 7(16):21753-62. PubMed ID: 26943041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin use is associated with a reduced risk of hepatocellular carcinoma recurrence after initial liver resection.
    Kawaguchi Y; Sakamoto Y; Ito D; Ito K; Arita J; Akamatsu N; Kaneko J; Hasegawa K; Moriya K; Kokudo N
    Biosci Trends; 2017 Nov; 11(5):574-580. PubMed ID: 29081488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of sorafenib (Nexavar) in the treatment of hepatocellular carcinoma: PRODIGE AFEF recommendations].
    Boige V; Barbare JC; Rosmorduc O;
    Gastroenterol Clin Biol; 2008 Jan; 32(1 Pt. 1):3-7. PubMed ID: 18341970
    [No Abstract]   [Full Text] [Related]  

  • 11. Selective induction of apoptosis by HMG-CoA reductase inhibitors in hepatoma cells and dependence on p53 expression.
    Kah J; Wüstenberg A; Keller AD; Sirma H; Montalbano R; Ocker M; Volz T; Dandri M; Tiegs G; Sass G
    Oncol Rep; 2012 Sep; 28(3):1077-83. PubMed ID: 22710979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins and risk reduction in hepatocellular carcinoma: fact or fiction?
    Singh PP; Singh S
    J Clin Oncol; 2012 Jul; 30(20):2569-70; author reply 2570-2571. PubMed ID: 22689810
    [No Abstract]   [Full Text] [Related]  

  • 13. Metastasis from Hepatocellular Carcinoma Masquerading as a Jugular Paraganglioma.
    Chaudhary D; Patkar S; Shrikhande SV; Goel M
    J Gastrointest Cancer; 2018 Dec; 49(4):517-519. PubMed ID: 28374273
    [No Abstract]   [Full Text] [Related]  

  • 14. Statins: A Panacea to Reduce Mortality in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma?
    Shawcross DL; Suddle A
    Liver Transpl; 2022 Mar; 28(3):357-358. PubMed ID: 34837475
    [No Abstract]   [Full Text] [Related]  

  • 15. A fishy nodule.
    Jarry J; Nguyen V; Imperato M
    Gastroenterology; 2012 Jan; 142(1):e26-7. PubMed ID: 22107715
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatocellular carcinoma: current management and perspectives for the future.
    Rahbari NN; Mehrabi A; Mollberg NM; Müller SA; Koch M; Büchler MW; Weitz J
    Ann Surg; 2011 Mar; 253(3):453-69. PubMed ID: 21263310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palliative chemoradiation in advanced hepatocellular carcinoma.
    Bair RJ; Weis JR; Clayton F; Glasgow RE; Gaffney DK
    J Clin Oncol; 2010 May; 28(15):e231-2. PubMed ID: 20308660
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatocellular carcinoma and sorafenib: too many resistance mechanisms?
    Berasain C
    Gut; 2013 Dec; 62(12):1674-5. PubMed ID: 23481262
    [No Abstract]   [Full Text] [Related]  

  • 19. Recent developments in systemic therapy for hepatocellular carcinoma.
    Zhu AX
    Clin Adv Hematol Oncol; 2017 Aug; 15 Suppl 9(8):7-13. PubMed ID: 29036037
    [No Abstract]   [Full Text] [Related]  

  • 20. Liver transplantation in a patient treated by sorafenib for hepatocellular carcinoma.
    Borentain P; Gregoire E; Hardwigsen J; Garcia S; Durieux O; Le Treut YP; Gérolami R
    Clin Res Hepatol Gastroenterol; 2011 Mar; 35(3):234-6. PubMed ID: 21345761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.